Profectus BioSciences Adds Funding
Profectus BioSciences Inc., a Baltimore-based developer of vaccines for chronic viral infections, has sealed an undisclosed amount of funding from the PATH Malaria Vaccine Initiative. Terms of the funding were not released. The company is backed by venture investors including Cross Atlantic Capital Partners.
15 November 2011•3 mins read
